Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Medigus Ltd. WT C EXP 072323 MDGSW NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
31/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Medigus Ltd. WT C EXP 072323 (MDGSW) is a Medical - Devices company in the Healthcare sector, currently trading at $0.02. It has a SharesGrow Score of 30/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $30M, +246.8%/yr average growth. Net income is $6M (loss), growing at -115.6%/yr. Net profit margin is -20.2% (negative). Gross margin is 22.4% (-25.1 pp trend).

Balance sheet: total debt is $7M against $18M equity (Debt-to-Equity (D/E) ratio 0.38, conservative). Current ratio is 1.14 (adequate). Debt-to-assets is 18.3%. Total assets: $38M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 25/100 (Fail), Health 50/100 (Partial), Moat 14/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

MDGSW SharesGrow Score Overview

31/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 25/100
strong — trend
HEALTH 50/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 14/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — MDGSW

—
VALUE N/A
N/A
No analyst coverage available for this stock.
~
GROWTH Partial
58/100
MDGSW: +246.8%/yr revenue is, -115.6%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
✗
PAST Fail
25/100
MDGSW: 1 / 4 years profitable. weak. Score = 1 / 4 × 100. ≥ 80 = Pass.
View details →
~
HEALTH Partial
50/100
Balance sheet MDGSW: Debt-to-Equity (D/E) ratio 0.38 (conservative), Current ratio is 1.14 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
14/100
MDGSW: Gross margin is 22.4% (-25.1 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 14/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
MDGSW: Net profit margin is -20.2%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.0213-0.0213
Volume5.57K
Beta (1Y)0.00
Share Statistics
EPS (TTM)-8.36
Shares Outstanding$720.83K
IPO Date2018-07-23
CEONone
Financial Highlights & Ratios
Revenue (TTM)$29.86M
Gross Profit$6.68M
EBITDA$-7.51M
Net Income$-6.03M
Operating Income$-8.02M
Total Cash$14.67M
Total Debt$6.86M
Net Debt$-1.89M
Total Assets$37.55M
Price / Earnings (P/E)-0
Analyst Forecast
Company Info
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD

Price Chart

Track all markets on TradingView
MDGSW
Medigus Ltd. WT C EXP 072323  ·  NASDAQ Capital Marke
Healthcare • Medical - Devices

People Also View

NESRW
NESRW
National Energy Services Reunited Corp.
$0.50
-13.06%
 IMACW
IMACW
IMAC Holdings, Inc.
$0.01
+10.09%
 PAVMZ
PAVMZ
PAVmed Inc
$0.00
-40.00%
 ADILW
ADILW
Adial Pharmaceuticals, Inc. WT EXP 073123
$0.00
-57.14%
 ENTXW
ENTXW
Entera Bio Ltd. WT EXP 062723
$0.00
-60.00%
 LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message